| 000 | 03728cam a2200577 i 4500 | ||
|---|---|---|---|
| 001 | ocn904012242 | ||
| 005 | 20250919141838.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 150223s2015 enk ob 001 0 eng | ||
| 010 | _a 2015007411 | ||
| 020 |
_a9781118385845 _q(ePub) |
||
| 020 |
_a1118385845 _q(ePub) |
||
| 020 |
_a9781118385784 _q(Adobe PDF) |
||
| 020 |
_a1118385780 _q(Adobe PDF) |
||
| 020 | _a9781118385777 | ||
| 020 | _a1118385772 | ||
| 029 | 1 |
_aNZ1 _b16093638 |
|
| 029 | 1 |
_aAU@ _b000058365801 |
|
| 029 | 1 |
_aDEBBG _bBV043397551 |
|
| 035 |
_a(OCoLC)904012242 _z(OCoLC)959273610 |
||
| 040 |
_aDLC _beng _erda _epn _cDLC _dNST _dDG1 _dYDXCP _dE7B _dOCLCF _dCDX _dEBLCP _dOCLCQ _dOCLCO _dOCLCQ _dDEBBG |
||
| 042 | _apcc | ||
| 049 | _aMAIN | ||
| 050 | 0 | 0 | _aRM315 |
| 060 | 1 | 0 | _aQV 76.5 |
| 072 | 7 |
_aMED _x071000 _2bisacsh |
|
| 082 | 0 | 0 |
_a615.7/8 _223 |
| 100 | 1 |
_aEbenezer, Ivor S., _eauthor. |
|
| 245 | 1 | 0 |
_aNeuropsychopharmacology and therapeutics / _cIvor S. Ebenezer. |
| 264 | 1 |
_aChichester, West Sussex ; _aHoboken, NJ : _bWiley-Blackwell, _c2015. |
|
| 300 | _a1 online resource. | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 500 | _aMachine generated contents note: Preface Chapter1. Introduction to Neuropsychopharmacology Chapter 2. Parkinson's Disease Chapter 3. Memory, Dementia and Alzheimer's Disease Chapter 4. Epilepsy Chapter 5. Attention Deficit Hyperactivity Disorder (ADHD) Chapter 6. Affective Disorders 1:Depression Chapter 7. Affective Disorders 2: Bipolar Disorders Chapter 8. Anxiety Disorders Chapter 9. Sleep and Sleep Disorders Chapter 10. Schizophrenia Chapter 11. Drug Abuse and Misuse Index. | ||
| 520 | _a'Neuropsychopharmacology is a relatively new subject area in the neurosciences. It is a field of study that describes the effects of drugs from the molecular to the behavioural level and requires integration and synthesis of knowledge from various disciplines including neuroanatomy, physiology, molecular biology, pharmacology and the behavioural sciences. The principal aims of this book are to provide students with a clear understanding of CNS disorders, and an appreciation of how basic and clinical research findings can be translated into therapeutics. After an introduction to the subject area, the remaining chapters are focused on reviewing the main psychiatric and neurological disorders that are covered in most courses. They are discussed in terms of their clinical symptoms, epidemiology, pathology, aetiology, underlying neurobiological and neurochemical mechanisms, pharmacotherapy, adjunctive non-pharmacological treatments, and clinical outcomes. Each chapter of the book is a'stand-alone' chapter and is written in a clear, accessible style. Written by an author with many years teaching and research experience, this textbook will prove invaluable for students of pharmacology, pharmacy and the medical sciences needing a truly integrated introduction to this exciting field'--Provided by publisher. | ||
| 650 | 0 | _aNeuropsychopharmacology. | |
| 650 | 0 | _aTherapeutics. | |
| 650 | 2 |
_aCentral Nervous System Agents _xtherapeutic use. |
|
| 650 | 2 |
_aCentral Nervous System Diseases _xdrug therapy. |
|
| 650 | 2 |
_aCentral Nervous System _xdrug effects. |
|
| 650 | 2 |
_aMental Disorders _xdrug therapy. |
|
| 650 | 2 |
_aNeuropharmacology _xmethods. |
|
| 856 | 4 | 0 | _uhttps://eresourcesptsl.ukm.remotexs.co/user/login?url=https://doi.org/10.1002/9781118385777 |
| 907 |
_a.b16816377 _b2022-10-07 _c2020-07-17 |
||
| 942 | _n0 | ||
| 998 |
_ae _b2020-07-17 _cm _dz _feng _genk _y0 _z.b16816377 |
||
| 999 |
_c649046 _d649046 |
||